Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vaping, Environmental Toxicants Exposure, and Lung Cancer Risk. | Cancers (Basel) | 2023 | 37760496 | PubTator, text mining | PubMed |
| Circulating Tumor Cell Subpopulations Predict Treatment Outcome in Pancreatic Ductal Adenocarcinoma (PDAC) Patients. | Cells | 2023 | 37759489 | PubTator, text mining | PubMed |
| Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer. | Clin Cancer Res | 2023 | 37756555 | PubTator, text mining | PubMed |
| Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk. | Nat Genet | 2023 | 37752376 | PubTator, text mining | PubMed |
| Structural insights into Rad18 targeting by the SLF1 BRCT domains. | J Biol Chem | 2023 | 37748650 | PubTator, text mining | PubMed |
| Diagnostics and treatment of ovarian cancer in the era of precision medicine - opportunities and challenges. | Front Oncol | 2023 | 37746296 | PubTator, text mining | PubMed |
| SENP6 regulates localization and nuclear condensation of DNA damage response proteins by group deSUMOylation. | Nat Commun | 2023 | 37735495 | PubTator, text mining | PubMed |
| Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer. | JAMA Oncol | 2023 | 37733366 | PubTator, text mining | PubMed |
| The Fanconi anemia core complex promotes CtIP-dependent end-resection to drive homologous recombination at DNA double-strand breaks. | bioRxiv | 2023 | 37732274 | PubTator, text mining | PubMed |
| Genomic profile of Chinese patients with endometrial carcinoma. | BMC Cancer | 2023 | 37730563 | PubTator, text mining | PubMed |
Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients. | Front Immunol | 2023 | 37727789 | PubTator, text mining | PubMed |
| Performance of a RAD51-based functional HRD test on paraffin-embedded breast cancer tissue. | Breast Cancer Res Treat | 2023 | 37725154 | PubTator, text mining | PubMed |
| Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer. | JAMA Netw Open | 2023 | 37721753 | PubTator, text mining | PubMed |
| Germline BRCA testing in pancreatic cancer: improving awareness, timing, turnaround, and uptake. | Ther Adv Med Oncol | 2023 | 37720496 | PubTator, text mining | PubMed |
A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresistance in Notch1-hyperactivated pancreatic cancer. | Cell Discov | 2023 | 37714834 | PubTator, text mining | PubMed |
| Increased expression of BRD4 isoforms long (BRD4-L) and short (BRD4-S) promotes chemotherapy resistance in high-grade serous ovarian carcinoma. | Genes Cancer | 2023 | 37705995 | PubTator, text mining | PubMed |
| Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC. | Thorac Cancer | 2023 | 37704455 | PubTator, text mining | PubMed |
| Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients. | Cancer Med | 2023 | 37694493 | PubTator, text mining | PubMed |
| C18ORF54 promotes immune infiltration and poor prognosis as a potential biomarker for hepatocellular carcinoma. | Am J Transl Res | 2023 | 37692934 | PubTator, text mining | PubMed |
| Patient-Derived Organoids as a Promising Tool for Multimodal Management of Sarcomas. | Cancers (Basel) | 2023 | 37686615 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=21